AMAM

Ambrx Biopharma, Inc. Common Stock
AMAM

Overview Fund Activity
Delisted

AMAM was delisted on the 6th of March, 2024.

Back to rankings

20 hedge funds and large institutions have $266M invested in Ambrx Biopharma, Inc. Common Stock in 2021 Q2 according to their latest regulatory filings, with 20 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

Holders
20
Holders Change
+20
Holders Change %
–
% of All Funds
0.35%
Holding in Top 10
1
Holding in Top 10 Change
+1
Holding in Top 10 Change %
%
% of All Funds
0.02%
New
20
Increased
–
Reduced
–
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

1
Fidelity Investments
1
Fidelity Investments
Massachusetts
$68.7M
2
CAM
2
Cormorant Asset Management
Massachusetts
$47M
3
FI
3
Fosun International
China
$37.9M
4
Adage Capital Partners
4
Adage Capital Partners
Massachusetts
$35.8M
5
SCM
5
Suvretta Capital Management
New York
$22.9M

Top Sellers

No sellers this quarter
Name Market Value Shares Shares
Change 		Shares
Change %
Fidelity Investments
1
Fidelity Investments
Massachusetts
$68.7M 3,766,940 +3,766,940 New
CAM
2
Cormorant Asset Management
Massachusetts
$47M 2,486,386 +2,486,386 New
FI
3
Fosun International
China
$37.9M 1,932,591 +1,932,591 New
Adage Capital Partners
4
Adage Capital Partners
Massachusetts
$35.8M 1,827,292 +1,827,292 New
SCM
5
Suvretta Capital Management
New York
$22.9M 1,169,529 +1,169,529 New
BlackRock
6
BlackRock
New York
$16.7M 850,676 +850,676 New
AG
7
Artal Group
Luxembourg
$16.7M 850,000 +850,000 New
OCA
8
Octagon Capital Advisors
New York
$8.82M 450,000 +450,000 New
Millennium Management
9
Millennium Management
New York
$2.82M 144,092 +144,092 New
MIM
10
Monashee Investment Management
Massachusetts
$2.16M 110,000 +110,000 New
AllianceBernstein
11
AllianceBernstein
Tennessee
$1.37M 70,000 +70,000 New
Norges Bank
12
Norges Bank
Norway
$1.37M 70,000 +70,000 New
Tudor Investment Corp
13
Tudor Investment Corp
Connecticut
$1.18M 60,000 +60,000 New
GCM
14
Ghisallo Capital Management
Massachusetts
$784K 40,000 +40,000 New
CCM
15
CAAS Capital Management
New York
$784K 40,000 +40,000 New
MWNA
16
Marshall Wace North America
New York
$640K 32,648 +32,648 New
PHP
17
Parkman Healthcare Partners
Connecticut
$294K 15,000 +15,000 New
BFM
18
Boothbay Fund Management
New York
$263K 13,422 +13,422 New
PCM
19
Pinz Capital Management
New York
$20K 1,000 +1,000 New
Bank of America
20
Bank of America
North Carolina
$2K 110 +110 New
CFGS
21
Concourse Financial Group Securities
Alabama
– – – –